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Background: When overweight or hypertension is present, some patients at first examination exhibit left
ventricular (LV) dilation and others concentric hypertrophy that persists indefinitely. Perhaps the ventricles
with the fewest myocytes could enter systolic dysfunction with dilation and those with more myocytes
may sustain persistent concentric hypertrophy.
Methods and Results: Cardiomyocyte numbers, MyN, were counted in paraffin sections of left ventricles
from 99 forensic autopsies, excluding instances of coronary heart disease. MyN lacked statistically signif-
icant relationships with age, race, sex, height, weight, LV mass, and mean arterial pressure estimated from
renal histology. Specimens with the fewest myocytes, however, did manifest significant dilation and thin-
ner chamber walls.
Conclusions: The tendency toward an eccentric pattern of hypertrophy in ventricles with the fewest
myocytes is a clear conclusion, but has an ambiguous interpretation. This is the pattern expected from
the initial hypothesis, but it also has other possible explanations. This ambiguity arises chiefly from
limitations in the methods used for estimating MyN. These limitations are accessible to control in future
studies. Our findings failed to contradict the hypothesis introduced here. These conclusions are implicit in
the underlying observations of MyN constancy across such groupings as sex, height, weight, and LV mass,
which provide the less speculative findings. (J Cardiac Fail 2013;19:517e522)
Key Words: Cardiomyopathy, heart failure, human, hypertension, obesity.Hypertensive subjects may or may not manifest left ven- patterns.5e9 Although retrospective data on morbid obesity
tricular (LV) hypertrophy when first observed.1e3 Those
with hypertrophy may reveal concentric or eccentric
patterns.2e4 The long-held view that the process begins as
concentric and evolves to eccentric hypertrophy is now sub-
ject to some doubt, because observations taken over a period
of years seldom encountered such an evolution in the ab-
sence of intervening myocardial infarction.4e7 Likewise,
newly assessed obese subjects may or may not have hyper-
trophy,1,8 and those with hypertrophy can display a broad
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r CC BY license.in place for up to 30 years found the duration of the condi-
tion to correlate strongly with progression to heart failure,
this was usually diastolic, implying an infrequent evolution
to systolic failure.8 Prospective studies offering follow-up
of O7.5 years found systolic dysfunction to evolve from
concentric hypertrophy in w20% of the cases in the ab-
sence of ischemic events.7 Therefore, the frequent finding
of eccentric hypertrophy on first examination of hyperten-
sive and overweight subjects raises the question of why
some subjects exhibit dilation and others remain in a state
of concentric hypertrophy without subsequent dilation.6 Re-
cent reports from our laboratory,10,11 using data derived
from forensic autopsies, reiterate these clinically derived
findings.
A readily developed hypothesis to reconcile these para-
doxic findings is that variations in the number of cardio-
myocytes might underlie these disparate responses to
cardiac work load. Ventricles with the fewest myocytes
could be the first ones to enter systolic dysfunction and
undergo dilatation. Ventricles with more myocytes could
be the ones that use concentric hypertrophy to compensate
for the work load. Uncommon ventricles with exceptionally
many myocytes might even adapt to the load without
enlarging the ventricular mass across pathologic boundary
Fig. 1. Cross-sectional planes of cut representing (A) smallest and
(B) largest sizes encountered in this study. Hematoxylin and eosin;
bars 5 50 mm.
518 Journal of Cardiac Failure Vol. 19 No. 7 July 2013lines. Unlike the situation for animal models, where evolu-
tion from concentric to eccentric hypertrophy is readily
induced, the human situation likely includes a wider range
of variation in the number of cardiomyocytes endowed dur-
ing infancy than is expected in laboratory animals. In the
human setting, the proposed hypothesis would predict that
an evolution from one form of hypertrophy to the other
ought to be uncommon and delayed, as it is observed to be.
The series of forensic autopsies previously reported is ex-
panded here by inclusion of newly assembled cases.With the
enlarged sample size, data on cardiomyocyte sizes deter-
mined histologically are used to explore the topic of
myocyte numbers (MyN) in relation to left ventricular
dimensions. The findings are the first of their kind and are
offered as provisional to further the proposed hypothesis.
Methods
Subjects
The 99 cases reported here were derived from a series of foren-
sic autopsies (Appendix). They included few women and had little
clinical information, as is usual for a forensic service. All subjects
with cardiomegaly were retained with the exception of those with
coronary heart disease, which were omitted. Comparison cases
without cardiomegaly were retained when time best permitted
this activity. The Institutional Review Board declared this autopsy
study to be exempt from their review.
Left Ventricular Measurements
Left ventricular chamber diameter (LVD), free wall thickness
(LVT), and mass (LVM) were measured during the autopsy on
the high chordal equatorial plane and expressed in millimeters
and grams (Appendix).
Preparations for Histology
A slice of myocardium presenting the high chordal plane was
formalin fixed for 1e3 weeks. Samples were excised perpendicular
to this plane from lateral and posterior ventricular walls. Paraffin-
embedded samples were sectioned at 6 mm and stained with
hematoxylin and eosin. To adjust for shrinkage in paraffin sections,
a factor of 1.21 was applied to subsequent histologic measure-
ments,10 although this was not needed for the relative comparisons
of myocyte characteristics in the specimens reported here.
Myocyte Profiles
Myocyte profiles in cross-section (Fig. 1) were evaluated by im-
posing an ellipse upon each profile and measuring the minor axis
of the idealized outline. These measurements were made on black-
and-white photographic prints with the use of a digital caliper
accurate to 0.01 mm. Measurements were taken in 60 anucleate
profiles from LV sites showing the best cross-sectional profiles
(4 sites in the first 78 cases and 2 sites in the 21 supplemental
cases). Figure 1A represents an exceptionally small ventricle
and 1B a greatly hypertrophied specimen, exemplifying the full
range of myocyte sizes in this data set. The irregular forms of
these cross-sections revealed especially great variation in the ma-
jor axis of the imposed ellipse, thus precluding confidence in its
measurement. For this reason, measurements were confined only
to the minor axis with no attempt to determine major axis.Separation of cells in these views is a shrinkage artifact from par-
affin embedding.
Myocyte Breadth (MyB), Cross-Sectional Area (MyA),
Length (MyL), Volume (MyV), and Number (MyN)
These quantities were all derived from measurements on cross-
sectional profiles like those in Figure 1, using LVM for computing
MyN. Details are provided in the Appendix.
Overweight
Cutoff for overweight was retained as used before, ie, weight
O104 kg, as described in the Appendix.
Hypertension
Intimal thickness of interlobular arteries in the renal cortex was
measured and mean arterial pressure (MAP) calculated with the
use of a previously derived regression equation10e13: MAP 5
(S þ 2  D)/3. The cutoff point of 106.7 mm Hg (eg, 140/90)
was used to specify hypertension in keeping with previous practice.
Statistical Methods
We used commonly used techniques available in the SAS pro-
grams (SAS Institute, Cary, North Carolina). Some of the linear
regression equations yielded insignificant intercept terms, so the
appropriate equations were forced through the origin; the squared
correlation coefficients reported with these equations are those re-
taining the intercept terms.
Fig. 2. Left: Each symbol presents 2-dimensional means of a single left ventricle; means of the grouped means are also plotted. The sloping
dashed lines plot LVM calculated from equation 1 (see text) in 3 groupings by myocyte numbers. Right: Means on the vertical axis in the
left panel are emphasized by bar graphs with SEM.
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Relationship of LVM to MyV
Three regression equations for this relationship were de-
rived, 1 for each of the groupings by LV MyN !4, 4e6,
and O6  109 myocytes per ventricle (Fig. 2). In each of
these 3 equations, a nonzero intercept term was found to
lack significance, so the appropriate equations were forced
through the origin (P values .85, .80, and .35 for the respec-
tive intercepts). Also lacking significance were the 3 qua-
dratic terms, MyV2, so LVM emerged as proportional to
MyV in all 3 myocyte groupings (P values .67, .14, and
.90 for the respective quadratic terms). Therefore
LVM5 b  MyV ð1Þ
with b5 0.0051, 0.0064, and 0.0083 andR25 0.92, 0.91, and
0.94 for the respective myocyte groupings. In the relationship
MyN5 0.75LVM/MyV, thevariations inMyNare, in these
data, governed solely by the denominator with no significant
contribution by the numerator. This is seen in Figure 2 by the
significant segregation of theMyN groupings on the horizon-
tal but not on the vertical axis (analysis of variance [ANOVA]
in the table), emphasized in the bar graph panel.Fig. 3. Left: An arbitrary line of proportionality is chosen to pass near
Means on the vertical axis in the left panel are emphasized by bar grapRelationship of MyA to LVD
Figure 3 shows a scatter plot of these 2 variables. The fit-
ted equation rejects an intercept term, so the appropriate
equation was forced through the origin:
MyA5 11:0  LVD 0:066  LVD2 ð2Þ

R250:44; SE of 11:0 is 0:66 and of  0:066 is 0:015
This equation is not plotted in Figure 3. In its place, an
arbitrary line of proportionality is introduced to aid discus-
sion, and this is chosen to pass near the means of the 3 MyN
groupings. The segregation of MyN groupings on the verti-
cal axis (MyA) is a stepwise progression, emphasized in the
bar graph panel, whereas on the horizontal axis (LVD) the
segregation is large from group !4 to 4e6 but small from
group 4e6 toO6, yielding a curvilinear pattern in keeping
with equation 2 (ANOVA in the table).
Relationship of Selected Variables to MyN
Groupings of cases on MyN did not significantly differ in
age, race, sex, height, weight, LVM, or MAP determined
from renal histology (Table 1). LVD had a weak positivethe 3 instances of 2-dimensional means to aid discussion. Right:
hs with SEM.
520 Journal of Cardiac Failure Vol. 19 No. 7 July 2013association (P 5 .04) and LVT a weak inverse association
(P 5 .03) with MyN. The ventricles with the fewest myo-
cytes tended to be somewhat dilated and with thinner free
walls compared with the ventricles with many myocytes.
Discussion
Myocyte numbers, as estimated here, display some
provocative patterns in this data set. These patterns are
not offered as definitive conclusions, but simply as provi-
sional observations to propose working hypotheses with
potentially useful consequences.
MyN did not differ significantly between men and women
nor between blacks and whites (Table 1; P5 .64 for interac-
tions). This would seem to imply that female infants receive
the same number of myocytes as male infants on average,
and that blacks receive the same numbers as whites. This
comparison of sex groupings extends the same concept intro-
duced by de Simone et al using different methodology.14
Therefore, the larger size of hearts in men could be due to ex-
aggerated hypertrophy of normal growth and not to greater
physiologic endowment with myocytes, as detailed in an
earlier report from this series of cases.10 Similar conclusions
apply to height, a proxy for lean body mass, as detailed
before.10 The endowment of myocytes in infancy appears
not to anticipate the adult body stature. Therefore, the larger
heart sizes in taller men and women may be due to exagger-
ated hypertrophy of normal growth, which would signal
accelerating progression toward pathologic boundaries in
persons of greater stature.
Body weight, a reflection in large part of fat body mass,10
did not correlate with MyN, nor did MAP, calculated from
renal histology (Table 1). Simplistically this would seem to
indicate that these sources of enhanced work load, acquiredTable 1. Means of Selected Variables by Number of Left
Ventricular Myocytes
Number of Myocytes  109 ANOVA
!4 4e6 O6 F P Value
MyB (mm) 21.1C 19.1B 17.4A 10.1 !.001
MyA (mm2) 360.3B 291.7A 245.4A 10.1 !.001
MyV (mm3  103) 49.7B 34.7A 29.5A 8.6 !.001
LVD (mm) 39.9B 33.7A 32.9A 3.2 .04
LVT (mm) 13.6A 14.7AB 15.5B 3.7 .03
LVM (G) 239.3A 223.2A 262.3A 1.4 .33
Weight (kg) 85.4A 95.3A 99.8A 1.4 .26
Height (m) 1.71A 1.74A 1.76A 1.6 .21
MAP (mm Hg) 103.6AB 104.2A 102.3A 0.2 .78
Age (y) 49.6A 46.1A 42.2A 1.2 .30
Race (% black) 50.0A 50.1A 60.0A 0.3 .76
Sex (% male) 75.0A 74.6A 83.3A 0.4 .69
MyN (109) 3.6A 4.9B 6.8C 213.8 !.001
No of cases 24 55 20
LV, left ventricular; LVD, LV chamber diameter; LVM, LV mass; LVT,
free wall thickness; MAP, mean arterial pressure 5 (systolic þ 2  dia-
stolic)/3; MyA, myocyte cross-sectional area; MyB, myocyte breadth;
MyN, total LV myocyte number; MyV, myocyte volume.
A,B,CMeans within a row that fail to share a symbol A, B, or C differ
significantly by the Tukey multiple range test.as adults, may not propel changes in myocyte numbers, ie,
hyperplasia, necrosis, or apoptosis, in this data set which ex-
cludes recognizable instances of coronary heart disease. This
interpretation is reinforced by the lack of correlation of MyN
with LVM (Table 1), indicating an equality of MyN across
groupings by LVM. That MyN might diminish by necrosis
or apoptosis in the most deformed ventricles was examined
in detail earlier, with the conclusion that the data were incon-
sistent with those suggestions.10 In specimens of all masses
and chamber sizes, the frequency distributions of myocyte
sizes did not reveal any truncation of the largest myocytes,
whereas the distributions continued to fit closely to a log nor-
mal even in the most hypertrophied and dilated ventricles.
An earlier comparison of hypertensive and overweight sub-
jects found no significant differences between them in
mean ventricular mass or diameter or their ranges of distribu-
tion.11 Pressure and volume overloads may vary in response
to overweight and hypertension in ways that are more nearly
similar than is often presumed. Grossman et al15 emphasized
the variations between pressure and volume overloads as de-
terminants of LV dimensions. Those principles were derived
from patients with valve defects where the types of overload
can be easily distinguished, whereas this is not so easily done
for overweight and hypertension.
Differences across groupings by MyN did emerge as sig-
nificant for LVD and LVT (Table 1). The ventricles with the
fewest myocytes were somewhat dilated and had slightly
thinner walls. The interpretation of this outcome is ambigu-
ous, because it carries a risk of circular reasoning. The mean
MyV, when used to calculate MyN, should appropriately be
calculated from the product of mean MyA times mean MyL.
The mean MyL was not accessible to measurement in this
study, and an approximation of this quantity was estimated
from LVD, giving MyV 5 3.654  MyA  LVD  103
mm (Appendix). This calls for a judgement about how to
account for the variations in LVD. In the formula MyN 5
0.75  LVM/(MyA  3.654  LVD  103)  109, the
values for MyN calculated here were fewer when LVD
increased with dilation. Whatever may account for the dila-
tion, this dilation does, in part, govern the calculated values
of MyN. An appropriate decision about the underlying
causes of the dilation must be deferred until better data
are in hand.
Conclusion
The hypothesis under exploration here offers one possi-
ble explanation for the variations in LVD across MyN
groupings: when MyN is small the ventricle seems vulner-
able to systolic dysfunction and subsequent dilatation. An-
other possibility is the dilatation that often happens during
a terminal course of progressive deterioration toward de-
mise. In future studies, these and other possibilities could
be sorted out by direct measurement of mean myocyte
length, thereby avoiding the potential for circular reason-
ing. For now it seems fair to conclude that the patterns in
the data do not contradict the proposed hypothesis and
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that the hypothesis therefore emerges as meriting further
exploration. These conclusions are implicit in the underly-
ing observations of myocyte number constancy across such
groupings as sex, height, weight, and LVMs, which provide
the less speculative findings.Acknowledgments
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Most of the methods used in this report are already pub-
lished10 and are presented here in brief.
Subjects
From November 2007 to May 2009, the Orleans Parish
Coroner’s Office supplied 78 specimens, as detailed previ-
ously.10 From January to September 2012, 21 more cases
were added to the series, yielding a total of 99 cases. All
cases with cardiomegaly (whole heart weight O399 g in
women and O449 g in men), other than coronary heart
disease (CHD), were included. CHD was recognized by
finding scars or grossly visible evidence of ongoing necro-
sis, often with chamber wall thinning, in company with cor-
onary artery narrowing, usually by calcific plaques, with or
without thrombosis. Noncardiovascular cases without car-
diomegaly were chosen to have!12 hours’ postmortem in-
terval, no immediately preceding hospitalization, and cause
of death unrelated to cardiovascular disease, emphasizing
tall women and short men. Later classification identified
21 subjects as hypertensive, 26 as overweight, and 10 as
both.
Left Ventricular Chamber Diameter (LVD), Free Wall
Thickness (LVT), and Mass (LVM)
Chamber diameter (LVD) and thicknesses of the poste-
rior (P), lateral (L), and septal (S) walls, all in millimeters,
were measured in the formalin-fixed heart slices with a cal-
iper on the ventricular high chordal plane (touching the
edges of the opened mitral leaflets). LVT is the mean of
posterior and lateral wall thicknesses. The mass of the
left ventricle in grams was calculated with the use of a slight
modification of the American Society of Echocardiology
formula16: LVM 5 0.8  (1.04  [S þ LVD þ L]3 
LVD3) þ 35. This differs from the formula preferred by
Devereux et al16 by replacing their constant term 0.6 with
the term 35. This change is apt to be a result of methodo-
logic variations between the 2 studies (eg, the series used
here placed the trabeculae carneae on the right side of the
interventricular septum with the right ventricle rather than
with the left). The term 35 is added to every specimen alike
and can not affect the correlations of interest reported here.
An equation relating LVM to weights of isolated ventricles
derived from a subset of 66 cases had regression coefficient
not significantly different from b 5 1 and rejecting nonzero
intercept (r 5 0.93), showing the calculated value to agree
precisely with the weight of the isolated ventricle with
gratifying precision.
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(MyA)
In the idealized model of a myocyte as an elliptic cylin-
der, the dimensions of its cross-section being major axis A
and minor axis B. The name ‘‘width’’ is often given to the
quantity 2r in the imaginary circle of radius r with area 5
pAB/4. However, the name ‘‘width’’ is also often used for
the major axis or for the minor axis, making the name
‘‘width’’ ambiguous. To avoid this ambiguity, the name
‘‘breadth’’ is given to the quantity 2r. For calculating the
mean of MyB needed here, r is calculated from the minor
axis as r 5 1.048  B, as derived previously.10 Mean
MyA is pr2. It was previously found in specimens of this
study that sarcomere lengths averaged closely w1.65 mm
in all specimens, indicating that the formalin-fixed post-
mortem state displays the myocytes in fully contracted sys-
tole thus removing this possible source of variation across
specimens.10
Myocyte Length (MyL), Volume (MyV), and Number
(MyN)
This study required only mean values for MyL and MyV
in each specimen and had no need for individual measure-
ments of each myocyte. In a study of maturing spontane-
ously hypertensive rats from birth to 24 months, many
with left ventricle hypertrophy, Tamura et al17 found
a regression equation relating mean MyL, determined
with enzymatically isolated cells in suspension, to chamber
circumference. Adaptation of that formula to the human
data proved to be surprisingly consistent with derived out-
comes reported here: MyL 5 (7  0.84  17.4  LVD/
28.0)  103 5 3.654  LVD  103 mm.10 From this,MyV 5 p  r2  MyL 5 MyA  MyL is then derived.
Total number of myocytes (MyN) in a ventricle then fol-
lows as MyN 5 0.75  LVM/MyV, ignoring the negligible
effect of specific gravity. The term 0.75 is a commonly re-
ported estimate10 of myocytes as a proportion of total LVM
(myocyte volume fraction), an estimate that should be mea-
sured for each specimen in future studies. The grouping of
cases into ranges of MyN of!4, 4e6, andO6  109 my-
ocytes is arbitrary to generate ample numbers of cases
within each interval.
Overweight
Body weight is the sum of lean plus fat masses with
proxies of height and body mass index (BMI; kg/m2), re-
spectively. It was found elsewhere10 that MyB had multiple
correlation with height2,7 and BMI that was indistinguish-
able from the correlation with total body weight, and
with equal importance for lean and fat masses in the rela-
tionship. Therefore, within this data set body weight was
better than BMI as a measure of overweight for the limited
purposes of this report.
Hypertension
Intimal thickness of interlobular arteries in the renal cor-
tex was measured, and mean arterial pressure (MAP) calcu-
lated with the use of a previously derived regression
equation10e13 (MAP 5 [S þ 2  D]/3). For the equation,
the correlation coefficient was r 5 0.702, showing a rela-
tively crude quantification of the desired blood pressure
levels. These are of limited worth for specifying values
for individuals but can be useful when comparing group
averages.
